Published in J Bone Miner Res on April 08, 2016
Procyanidins Mitigate Osteoarthritis Pathogenesis by, at Least in Part, Suppressing Vascular Endothelial Growth Factor Signaling. Int J Mol Sci (2016) 0.75
TNF-α-induced LRG1 promotes angiogenesis and mesenchymal stem cell migration in the subchondral bone during osteoarthritis. Cell Death Dis (2017) 0.75
Bone-cartilage crosstalk: a conversation for understanding osteoarthritis. Bone Res (2016) 0.75
In vivo immunotherapy of lung cancer using cross-species reactive vascular endothelial growth factor nanobodies. Iran J Basic Med Sci (2017) 0.75
Vascular Endothelial Growth Factor in Cartilage Development and Osteoarthritis. Sci Rep (2017) 0.75
Wogonoside inhibits IL-1β induced catabolism and hypertrophy in mouse chondrocyte and ameliorates murine osteoarthritis. Oncotarget (2017) 0.75
The biology of VEGF and its receptors. Nat Med (2003) 32.13
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum (2008) 19.80
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol (1996) 15.20
Vascular-specific growth factors and blood vessel formation. Nature (2000) 14.42
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell (1997) 13.94
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum (1998) 12.36
VEGF receptor signalling - in control of vascular function. Nat Rev Mol Cell Biol (2006) 12.09
Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev (2004) 11.69
Burden of major musculoskeletal conditions. Bull World Health Organ (2003) 10.89
Vascular endothelial growth factor (VEGF) and its receptors. FASEB J (1999) 10.09
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer. Nat Rev Drug Discov (2004) 9.96
VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med (1999) 9.18
The effects of specific medical conditions on the functional limitations of elders in the Framingham Study. Am J Public Health (1994) 7.38
Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med (2015) 7.08
Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med (2002) 5.50
Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood (1996) 5.31
Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature (1987) 5.24
Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci U S A (2002) 4.46
Tanezumab for the treatment of pain from osteoarthritis of the knee. N Engl J Med (2010) 4.15
Molecular mechanisms of blood vessel growth. Cardiovasc Res (2001) 3.94
Macrophages and angiogenesis. J Leukoc Biol (1994) 3.85
Transcriptional regulation of endochondral ossification by HIF-2alpha during skeletal growth and osteoarthritis development. Nat Med (2010) 3.59
The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J Biol Chem (1996) 3.53
Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest (1997) 3.39
Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. Arthritis Rheum (2003) 3.29
The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol (2010) 3.14
The codependence of angiogenesis and chronic inflammation. FASEB J (1997) 3.02
Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants. J Biol Chem (2000) 2.87
Intracellular VEGF regulates the balance between osteoblast and adipocyte differentiation. J Clin Invest (2012) 2.58
Calcification of articular cartilage in human osteoarthritis. Arthritis Rheum (2009) 2.58
Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. Chem Biol (1997) 2.38
Review: angiogenesis: implications for rheumatoid arthritis. Arthritis Rheum (1998) 2.38
The role of synovitis in osteoarthritis pathogenesis. Bone (2012) 2.37
Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford) (2004) 2.33
Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech Dev (2001) 2.20
Chondrocyte apoptosis induced by nitric oxide. Am J Pathol (1995) 2.16
Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum (2003) 2.15
Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J Exp Med (1999) 2.13
Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett (1995) 2.09
Endostatin blocks vascular endothelial growth factor-mediated signaling via direct interaction with KDR/Flk-1. J Biol Chem (2002) 1.98
Plasma proteins present in osteoarthritic synovial fluid can stimulate cytokine production via Toll-like receptor 4. Arthritis Res Ther (2012) 1.79
Multiple roles of vascular endothelial growth factor (VEGF) in skeletal development, growth, and repair. Curr Top Dev Biol (2005) 1.75
Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis. Rheumatology (Oxford) (2010) 1.74
Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis. Arthritis Rheum (2001) 1.74
Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone (2002) 1.72
Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J Immunol (2004) 1.71
Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye (Lond) (2013) 1.67
Gene therapy targeting the Tie2 function ameliorates collagen-induced arthritis and protects against bone destruction. Arthritis Rheum (2005) 1.67
Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation (1997) 1.66
Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RGD. Proc Natl Acad Sci U S A (1998) 1.66
The splice variants VEGF121 and VEGF189 of the angiogenic peptide vascular endothelial growth factor are expressed in osteoarthritic cartilage. Arthritis Rheum (2001) 1.64
The role of synovial macrophages and macrophage-produced mediators in driving inflammatory and destructive responses in osteoarthritis. Arthritis Rheum (2010) 1.63
Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. Nat Rev Rheumatol (2012) 1.62
Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells. Diabetes (1999) 1.60
Chondromodulin 1 stabilizes the chondrocyte phenotype and inhibits endochondral ossification of porcine cartilage repair tissue. Arthritis Rheum (2011) 1.57
Angiogenesis in the synovium and at the osteochondral junction in osteoarthritis. Osteoarthritis Cartilage (2007) 1.57
The evolving role of obesity in knee osteoarthritis. Curr Opin Rheumatol (2010) 1.55
Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem Biophys Res Commun (1994) 1.55
The basic science of the subchondral bone. Knee Surg Sports Traumatol Arthrosc (2010) 1.55
Alteration of sensory neurons and spinal response to an experimental osteoarthritis pain model. Arthritis Rheum (2010) 1.51
Vascular endothelial growth factor (VEGF) directly enhances osteoclastic bone resorption and survival of mature osteoclasts. FEBS Lett (2000) 1.50
Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis. Lab Invest (2000) 1.50
Roles for VEGF in the adult. Microvasc Res (2007) 1.48
A systematic review of the adverse events of intravitreal anti-vascular endothelial growth factor injections. Retina (2011) 1.47
Vascular endothelial growth factor modulates neutrophil transendothelial migration via up-regulation of interleukin-8 in human brain microvascular endothelial cells. J Biol Chem (2002) 1.46
Expression of muscle anabolic and metabolic factors in mechanically loaded MLO-Y4 osteocytes. Am J Physiol Endocrinol Metab (2011) 1.45
The vascularity and remodelling of subchondrial bone and calcified cartilage in adult human femoral and humeral heads. An age- and stress-related phenomenon. J Bone Joint Surg Br (1977) 1.45
Osteoarthritis as a disease of mechanics. Osteoarthritis Cartilage (2012) 1.44
Vascular endothelial growth factor isoforms and their receptors are expressed in human osteoarthritic cartilage. Am J Pathol (2003) 1.42
Differential expression of vascular endothelial growth factor (vascular permeability factor) forms in rat tissues. Growth Factors (1995) 1.40
Thrombospondins function as regulators of angiogenesis. J Cell Commun Signal (2009) 1.40
The role of T cells in the pathogenesis of osteoarthritis. Arthritis Rheum (2007) 1.39
Vascular endothelial growth factor in articular cartilage of healthy and osteoarthritic human knee joints. Ann Rheum Dis (2001) 1.38
Hypertrophy is induced during the in vitro chondrogenic differentiation of human mesenchymal stem cells by bone morphogenetic protein-2 and bone morphogenetic protein-4 gene transfer. Arthritis Res Ther (2009) 1.34
Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1beta. J Rheumatol (1997) 1.33
Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease. Surv Ophthalmol (2011) 1.32
Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble Flt-1. Arthritis Rheum (2009) 1.31
Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: effect on human microvascular endothelial cell proliferation and angiogenesis. Angiogenesis (1999) 1.31
Contributions of angiogenesis to inflammation, joint damage, and pain in a rat model of osteoarthritis. Arthritis Rheum (2011) 1.31
Possible involvement of the vascular endothelial growth factor-Flt-1-focal adhesion kinase pathway in chemotaxis and the cell proliferation of osteoclast precursor cells in arthritic joints. J Immunol (2002) 1.29
Bevacizumab for neovascular ocular diseases. Ann Pharmacother (2007) 1.29
Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice. Biochem Biophys Res Commun (2001) 1.28
Thrombospondin-1 inhibits VEGF receptor-2 signaling by disrupting its association with CD47. J Biol Chem (2010) 1.27
Vascular endothelial growth factor (VEGF) induces matrix metalloproteinase expression in immortalized chondrocytes. J Pathol (2004) 1.25
Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis. J Immunol (2000) 1.25
Hypoxia-inducible factor 2alpha is essential for hypoxic induction of the human articular chondrocyte phenotype. Arthritis Rheum (2007) 1.25
Antagonism of nerve growth factor-TrkA signaling and the relief of pain. Anesthesiology (2011) 1.25
Blockade of vascular endothelial growth factor receptor I (VEGF-RI), but not VEGF-RII, suppresses joint destruction in the K/BxN model of rheumatoid arthritis. J Immunol (2003) 1.25
Age-related changes in the thickness of the calcified zone and the number of tidemarks in adult human articular cartilage. J Bone Joint Surg Br (1980) 1.24
Human neutrophils secrete vascular endothelial growth factor. J Leukoc Biol (1997) 1.23
TNP-470: an angiogenesis inhibitor in clinical development for cancer. Expert Opin Investig Drugs (2000) 1.23
Expression of the cartilage derived anti-angiogenic factor chondromodulin-I decreases in the early stage of experimental osteoarthritis. J Rheumatol (2003) 1.23
VEGF receptor 1 signaling is essential for osteoclast development and bone marrow formation in colony-stimulating factor 1-deficient mice. Proc Natl Acad Sci U S A (2005) 1.23
Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review. Osteoarthritis Cartilage (2013) 1.22
The potential role of vascular endothelial growth factor (VEGF) in cartilage: how the angiogenic factor could be involved in the pathogenesis of osteoarthritis? Osteoarthritis Cartilage (2007) 1.22
Vascular endothelial growth factor receptors in osteoclast differentiation and function. Biochem Biophys Res Commun (2005) 1.21
Blood-induced joint disease: the pathophysiology of hemophilic arthropathy. J Thromb Haemost (2010) 1.20
Upregulated hypoxia inducible factor-1alpha and -2alpha pathway in rheumatoid arthritis and osteoarthritis. Arthritis Res Ther (2003) 1.20
T cells and T-cell cytokine transcripts in the synovial membrane in patients with osteoarthritis. Clin Diagn Lab Immunol (1998) 1.20
Increased vascular penetration and nerve growth in the meniscus: a potential source of pain in osteoarthritis. Ann Rheum Dis (2010) 1.19
Author reply: "correlation of aspiration results with periprosthetic sepsis in revision total hip arthroplasty". J Arthroplasty (2013) 1.07
SHP2-Deficiency in Chondrocytes Deforms Orofacial Cartilage and Ciliogenesis in Mice. J Bone Miner Res (2015) 0.76